Neuraminidase Inhibitor [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Neuraminidase Inhibitor [EPC] includes 2 drugs with a combined 12,070 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
12,070
Combined Reports
All Neuraminidase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| OSELTAMIVIR | oseltamavir phosphate | 11,686 | 1,045 | 2,284 | 8.9% |
| ZANAMIVIR | RELENZA | 384 | 123 | 112 | 32.0% |
Common Side Effects in Neuraminidase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Vomiting | 1,566 | 184 |
| Off label use | 1,538 | 285 |
| Nausea | 1,066 | 180 |
| No adverse event | 810 | 6 |
| Drug ineffective | 703 | 216 |
| Dyspnoea | 599 | 119 |
| Diarrhoea | 565 | 4 |
| Hallucination | 509 | 3 |
| Influenza | 454 | 55 |
| Rash | 448 | 3 |